文献速递肿瘤 PET/CT

68Ga-PSMA-11 PET/CT在前列腺癌初始分期中应用:南非黑人与白人患者差异的初步结果

68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-11-04

该研究报告77例南非黑人(BSA)与18例南非白人(WSA)未经治疗的原发性前列腺癌(PPC)患者的68Ga-PSMA-11 PET/CT表现差异。95例中93例原发灶可识别;Gleason分级组3患者中位SUVmax与血清PSA显著高于组1和组2,SUVmax与血清PSA显著相关(r=0.377,p=0.0001)。BSA中位PSA与SUVmax均显著高于WSA,经Gleason评分标准化后中位SUVmax在BSA中为WSA的2.5倍(p=0.005)。

要点

  • 95例原发前列腺癌中93例在68Ga-PSMA-11 PET/CT上可识别原发灶。
  • Gleason分级组3的中位SUVmax 16.4与中位PSA 180 ng/ml显著高于组1和组2。
  • BSA中位PSA 81.6 ng/ml与中位SUVmax 11.9均显著高于WSA的14.5 ng/ml与4.38。

核心结论

  • SUVmax与Gleason分级组显著相关,且在BSA中显著高于WSA。
  • SUVmax与血清PSA显著相关,而血清PSA在BSA中显著高于WSA。

研究设计与样本

  • 该研究纳入77例南非黑人(BSA)与18例南非白人(WSA)未经治疗的原发性前列腺癌(PPC)患者,比较68Ga-PSMA-11 PET/CT表现与组织学、生化及形态学影像数据。
  • 患者按Gleason评分分为三组:GG1(3+3和3+4)、GG2(4+3和4+4)、GG3(9和10),并测定组间PSA差异。
  • 该研究还评估了原发肿瘤SUVmax的种族间差异及其与血清PSA的相关性。

主要发现

  • 95例原发性前列腺癌中93例在68Ga-PSMA-11 PET/CT上可识别。
  • GG3患者中位SUVmax 16.4与中位血清PSA 180 ng/ml显著高于GG1患者(中位9.6与25.1 ng/ml)及GG2患者(中位8.8与46.2 ng/ml)(p=0.033和p=0.003)。
  • SUVmax与血清PSA显著相关(r=0.377,p=0.0001)。
  • 年龄、淋巴结受累频率、远处转移频率及Gleason分级组在BSA与WSA间相似(p≥0.153)。
  • BSA中位血清PSA 81.6 ng/ml显著高于WSA的14.5 ng/ml(p=0.0001),BSA中位SUVmax 11.9显著高于WSA的4.38(p=0.004);经Gleason评分标准化后中位SUVmax在BSA中为WSA的2.5倍(p=0.005)。

关键数值与推荐

  • GG1定义为Gleason评分3+3和3+4,GG2定义为4+3和4+4,GG3定义为9和10。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The incidence of prostate cancer is 60% higher and the mortality rate is two- to three-times greater in black versus white men. We report on differences in 68Ga-PSMA-11 PET/CT imaging findings in 77 black South-African (BSAs) and 18 white South-African (WSAs) treatment-naïve primary prostate carcinoma (PPC) patients. METHODS: 68Ga-PSMA-11 PET/CT imaging findings were compared to histological, biochemical and morphological imaging data. Patients were grouped into three Gleason grade groups (GG), GG 1 (scores 3 + 3 and 3 + 4), GG2 (scores 4 + 3 and 4 + 4) and GG3 (scores 9 and 10), and the PSA difference among the groups was determined. Inter-racial difference in SUVmax of the primary tumor as well as its correlation with serum PSA were also determined. RESULTS: Ninety-three out of 95 PPC where readily identified on 68Ga-PSMA-11 PET/CT imaging. Median PPC SUVmax and serum PSA values proved significantly higher (p = 0.033 and p = 0.003) in GG3 patients (median 16.4 and 180 ng/ml) when compared to GG1 patients (median 9.6 and 25.1 ng/ml) or GG2 patients (median 8.8 and 46.2 ng/ml). SUVmax significantly correlated with serum PSA-values (r = 0.377 (p = 0.0001)). Age, frequency of lymph node involvement and distant metastases, and GGs (p ≥ 0.153) were similar in BSAs and WSAs, both median serum PSA-values as well as SUVmax values proved significantly higher in BSAs when compared to WSAs, respectively, 81.6 ng/ml versus 14.5 ng/ml (p = 0.0001) and 11.9 versus 4.38 (p = 0.004). Moreover, Gleason-score normalized median SUVmax values proved 2.5 times higher in BSAs when compared to WSAs (p = 0.005). CONCLUSION: SUVmax values proved significantly related to GG and to be significantly higher in BSAs when compared to WSAs. Also, SUVmax significantly correlated with serum PSA values, which was significantly higher in BSAs when compared with WSAs.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Sathekge M, Lengana T, Maes A, et al. 68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans. Eur J Nucl Med Mol Imaging. 2017. PMID: 29101444. doi:10.1007/s00259-017-3852-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。